Click here to get full coverage on POST-SCD Investigations Provide Insights Into Community Burden of SCD - American College of Cardiology

POST-SCD Investigations Provide Insights Into Community Burden of SCD  American College of Cardiology

POST-SCD Investigations Provide Insights Into Community Burden of SCD - American College of Cardiology

Click here to get full coverage on A Review of SCDS’s ‘Journey Through Ruth’ - The Commentator

A Review of SCDS’s ‘Journey Through Ruth’  The Commentator

A Review of SCDS’s ‘Journey Through Ruth’ - The Commentator

Click here to get full coverage on Behavioral Patterns of SCDS and Institutional Flows - news.stocktradersdaily.com

Behavioral Patterns of SCDS and Institutional Flows  news.stocktradersdaily.com

Behavioral Patterns of SCDS and Institutional Flows - news.stocktradersdaily.com

Click here to get full coverage on Practical Considerations for Implementing SCD Gene Therapy Into Clinical Use - CGTLive®

Practical Considerations for Implementing SCD Gene Therapy Into Clinical Use  CGTLive®

Practical Considerations for Implementing SCD Gene Therapy Into Clinical Use - CGTLive®

Click here to get full coverage on STArT Trial: Lessons, New Directions for Arginine Studies in Pediatric SCD Vaso-Occlusive Pain - Docwire News

STArT Trial: Lessons, New Directions for Arginine Studies in Pediatric SCD Vaso-Occlusive Pain  Docwire News

STArT Trial: Lessons, New Directions for Arginine Studies in Pediatric SCD Vaso-Occlusive Pain - Docwire News

Click here to get full coverage on Superior canal dehiscence syndrome induces canal-specific kinematic adaptations during locomotion - Nature

Superior canal dehiscence syndrome induces canal-specific kinematic adaptations during locomotion  Nature

Superior canal dehiscence syndrome induces canal-specific kinematic adaptations during locomotion - Nature

Click here to get full coverage on Long-Term Follow-Up of SCD Patients Following Curative Treatment - Hematology Advisor

Long-Term Follow-Up of SCD Patients Following Curative Treatment  Hematology Advisor

Long-Term Follow-Up of SCD Patients Following Curative Treatment - Hematology Advisor

Click here to get full coverage on Asthma seven times more likely in SCD children than in unaffected siblings - Sickle Cell Disease News

Asthma seven times more likely in SCD children than in unaffected siblings  Sickle Cell Disease News

Asthma seven times more likely in SCD children than in unaffected siblings - Sickle Cell Disease News

Click here to get full coverage on Phase 3 HIBISCUS: Etavopivat Cuts VOC Events, Improves Hemoglobin in SCD - HCPLive

Phase 3 HIBISCUS: Etavopivat Cuts VOC Events, Improves Hemoglobin in SCD  HCPLive

Phase 3 HIBISCUS: Etavopivat Cuts VOC Events, Improves Hemoglobin in SCD - HCPLive

Click here to get full coverage on Journal Club: Is outpatient management sufficient for some febrile patients with SCD? - Contemporary Pediatrics

Journal Club: Is outpatient management sufficient for some febrile patients with SCD?  Contemporary Pediatrics

Journal Club: Is outpatient management sufficient for some febrile patients with SCD? - Contemporary Pediatrics

Click here to get full coverage on SCDS Annual Showcase Draws Huge Crowd to Celebrate “Songs of Courage and Strength” - The Commentator

SCDS Annual Showcase Draws Huge Crowd to Celebrate “Songs of Courage and Strength”  The Commentator

SCDS Annual Showcase Draws Huge Crowd to Celebrate “Songs of Courage and Strength” - The Commentator

Click here to get full coverage on (SCDS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

(SCDS) Movement Within Algorithmic Entry Frameworks  news.stocktradersdaily.com

(SCDS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Click here to get full coverage on PIONEER Trial Update: Pociredir Shows Potential to Improve SCD Outcomes - Docwire News

PIONEER Trial Update: Pociredir Shows Potential to Improve SCD Outcomes  Docwire News

PIONEER Trial Update: Pociredir Shows Potential to Improve SCD Outcomes - Docwire News

Click here to get full coverage on Clinical Quiz: National Alliance of Sickle Cell Centers Consensus Recommendations on SCD Screening and Management - Hematology Advisor

Clinical Quiz: National Alliance of Sickle Cell Centers Consensus Recommendations on SCD Screening and Management  Hematology Advisor

Clinical Quiz: National Alliance of Sickle Cell Centers Consensus Recommendations on SCD Screening and Management - Hematology Advisor

Click here to get full coverage on Early results of trial testing tebapivat in SCD expected later this year - Sickle Cell Disease News

Early results of trial testing tebapivat in SCD expected later this year  Sickle Cell Disease News

Early results of trial testing tebapivat in SCD expected later this year - Sickle Cell Disease News

Click here to get full coverage on Myeloid Leukemias in SCD: Is Clonal Hematopoiesis the Root? - Docwire News

Myeloid Leukemias in SCD: Is Clonal Hematopoiesis the Root?  Docwire News

Myeloid Leukemias in SCD: Is Clonal Hematopoiesis the Root? - Docwire News

Click here to get full coverage on $3M Breakthrough Prize honors duo whose work changed SCD treatment - Sickle Cell Disease News

$3M Breakthrough Prize honors duo whose work changed SCD treatment  Sickle Cell Disease News

$3M Breakthrough Prize honors duo whose work changed SCD treatment - Sickle Cell Disease News

Click here to get full coverage on Agios to seek accelerated approval in US of oral mitapivat for SCD - Sickle Cell Disease News

Agios to seek accelerated approval in US of oral mitapivat for SCD  Sickle Cell Disease News

Agios to seek accelerated approval in US of oral mitapivat for SCD - Sickle Cell Disease News

Click here to get full coverage on Screening tool identifies developmental risks in young children with SCD: Study - Sickle Cell Disease News

Screening tool identifies developmental risks in young children with SCD: Study  Sickle Cell Disease News

Screening tool identifies developmental risks in young children with SCD: Study - Sickle Cell Disease News

Click here to get full coverage on Researchers aim to repurpose diabetes drug to treat SCD kidneys - Sickle Cell Disease News

Researchers aim to repurpose diabetes drug to treat SCD kidneys  Sickle Cell Disease News

Researchers aim to repurpose diabetes drug to treat SCD kidneys - Sickle Cell Disease News

Click here to get full coverage on The Cure for Everything by Michelle A. Williams, SM ’88, ScD ’91 - Harvard T.H. Chan School of Public Health

The Cure for Everything by Michelle A. Williams, SM ’88, ScD ’91  Harvard T.H. Chan School of Public Health

The Cure for Everything by Michelle A. Williams, SM ’88, ScD ’91 - Harvard T.H. Chan School of Public Health

Click here to get full coverage on ‘Stand up, fight back’ | SCDS holds anti-ICE protest, sparking confrontation - The Daily Collegian

‘Stand up, fight back’ | SCDS holds anti-ICE protest, sparking confrontation  The Daily Collegian

‘Stand up, fight back’ | SCDS holds anti-ICE protest, sparking confrontation - The Daily Collegian

Click here to get full coverage on ‘I’m angry, I’m tired’ | Students, community members organize to honor Renee Good, protest ICE violence - The Daily Collegian

‘I’m angry, I’m tired’ | Students, community members organize to honor Renee Good, protest ICE violence  The Daily Collegian

‘I’m angry, I’m tired’ | Students, community members organize to honor Renee Good, protest ICE violence - The Daily Collegian

Click here to get full coverage on Fresenius/SCD’s Application for Biosimilar Aflibercept Accepted for Review by FDA - Pearce IP

Fresenius/SCD’s Application for Biosimilar Aflibercept Accepted for Review by FDA  Pearce IP

Fresenius/SCD’s Application for Biosimilar Aflibercept Accepted for Review by FDA - Pearce IP

Click here to get full coverage on Fresenius/SCD Settle US Biosimilar Aflibercept Dispute with Regeneron - Pearce IP

Fresenius/SCD Settle US Biosimilar Aflibercept Dispute with Regeneron  Pearce IP

Fresenius/SCD Settle US Biosimilar Aflibercept Dispute with Regeneron - Pearce IP

Click here to get full coverage on SCD launches “Robin” family of 12µm LWIR uncooled detectors, advancing high-dynamic thermal imaging for next-generation defense systems - EDR Magazine - European Defence Review

SCD launches “Robin” family of 12µm LWIR uncooled detectors, advancing high-dynamic thermal imaging for next-generation defense systems  EDR Magazine - European Defence Review

SCD launches “Robin” family of 12µm LWIR uncooled detectors, advancing high-dynamic thermal imaging for next-generation defense systems - EDR Magazine - European Defence Review

Click here to get full coverage on Should High ED Utilization Be Redefined for Patients With SCD? - Hematology Advisor

Should High ED Utilization Be Redefined for Patients With SCD?  Hematology Advisor

Should High ED Utilization Be Redefined for Patients With SCD? - Hematology Advisor

Click here to get full coverage on Beam Therapeutics Announces Publication of BEACON Phase 1/2 - GlobeNewswire

Beam Therapeutics Announces Publication of BEACON Phase 1/2  GlobeNewswire

Beam Therapeutics Announces Publication of BEACON Phase 1/2 - GlobeNewswire

Click here to get full coverage on AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - Zacks Investment Research

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD  Zacks Investment Research

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - Zacks Investment Research

Click here to get full coverage on Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more - FirstWord Pharma

Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more  FirstWord Pharma

Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more - FirstWord Pharma

Click here to get full coverage on Air pollution may worsen chest syndrome in SCD, study finds - Sickle Cell Disease News

Air pollution may worsen chest syndrome in SCD, study finds  Sickle Cell Disease News

Air pollution may worsen chest syndrome in SCD, study finds - Sickle Cell Disease News

Click here to get full coverage on Pfizer's SCD drug fails phase 3 study in latest blow to Global Blood Therapeutics' legacy - Fierce Biotech

Pfizer's SCD drug fails phase 3 study in latest blow to Global Blood Therapeutics' legacy  Fierce Biotech

Pfizer's SCD drug fails phase 3 study in latest blow to Global Blood Therapeutics' legacy - Fierce Biotech

Click here to get full coverage on Muscle Gains vs Heart Strain: A Deadly Trade-off? - Medscape

Muscle Gains vs Heart Strain: A Deadly Trade-off?  Medscape

Muscle Gains vs Heart Strain: A Deadly Trade-off? - Medscape

Click here to get full coverage on IMOD Director General Visits SCD - משרד הביטחון - דף הבית

IMOD Director General Visits SCD  משרד הביטחון - דף הבית

IMOD Director General Visits SCD - משרד הביטחון - דף הבית

Click here to get full coverage on VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD - TCTMD.com

VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD  TCTMD.com

VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD - TCTMD.com

Click here to get full coverage on Sickle Cell Data Collection (SCDC) Program - Centers for Disease Control and Prevention | CDC (.gov)

Sickle Cell Data Collection (SCDC) Program  Centers for Disease Control and Prevention | CDC (.gov)

Sickle Cell Data Collection (SCDC) Program - Centers for Disease Control and Prevention | CDC (.gov)

Click here to get full coverage on Arts & Culture: A Play Within a Play: A Review of SCDS’s ‘The Anastasia Trials in the Court of Women’ - The Commentator

Arts & Culture: A Play Within a Play: A Review of SCDS’s ‘The Anastasia Trials in the Court of Women’  The Commentator

Arts & Culture: A Play Within a Play: A Review of SCDS’s ‘The Anastasia Trials in the Court of Women’ - The Commentator

Click here to get full coverage on Zinc Supplementation Does Not Reduce Severe Infection Rates Among Children With SCD - Hematology Advisor

Zinc Supplementation Does Not Reduce Severe Infection Rates Among Children With SCD  Hematology Advisor

Zinc Supplementation Does Not Reduce Severe Infection Rates Among Children With SCD - Hematology Advisor

Click here to get full coverage on SCD wins $115m Defense Ministry infrared sensor deal - Globes - Israel Business News

SCD wins $115m Defense Ministry infrared sensor deal  Globes - Israel Business News

SCD wins $115m Defense Ministry infrared sensor deal - Globes - Israel Business News

Click here to get full coverage on Are Sequential Compression Devices Effective at Reducing DVT Risk in ICU Patients? - Medscape

Are Sequential Compression Devices Effective at Reducing DVT Risk in ICU Patients?  Medscape

Are Sequential Compression Devices Effective at Reducing DVT Risk in ICU Patients? - Medscape

Click here to get full coverage on Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD - AJMC

Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD  AJMC

Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD - AJMC

Click here to get full coverage on SCDS Steals the Show in “The Game’s Afoot” - The Commentator

SCDS Steals the Show in “The Game’s Afoot”  The Commentator

SCDS Steals the Show in “The Game’s Afoot” - The Commentator

Click here to get full coverage on Mitapivat Shows Durable Therapeutic Benefits and Favorable Safety in SCD - Hematology Advisor

Mitapivat Shows Durable Therapeutic Benefits and Favorable Safety in SCD  Hematology Advisor

Mitapivat Shows Durable Therapeutic Benefits and Favorable Safety in SCD - Hematology Advisor

Click here to get full coverage on SCDS Stock Fund Price and Chart — NASDAQ:SCDS - TradingView

SCDS Stock Fund Price and Chart — NASDAQ:SCDS  TradingView

SCDS Stock Fund Price and Chart — NASDAQ:SCDS - TradingView

Click here to get full coverage on CLIMB SCD-121 Study Shows Exagamglogene Autotemcel Reduces VOCs in Sickle Cell Disease - Docwire News

CLIMB SCD-121 Study Shows Exagamglogene Autotemcel Reduces VOCs in Sickle Cell Disease  Docwire News

CLIMB SCD-121 Study Shows Exagamglogene Autotemcel Reduces VOCs in Sickle Cell Disease - Docwire News

Click here to get full coverage on Review Assesses Current, Emerging Therapies for Kidney Manifestations in SCD - AJMC

Review Assesses Current, Emerging Therapies for Kidney Manifestations in SCD  AJMC

Review Assesses Current, Emerging Therapies for Kidney Manifestations in SCD - AJMC

Click here to get full coverage on Research Advances in Otology at Johns Hopkins and Beyond - Johns Hopkins Medicine

Research Advances in Otology at Johns Hopkins and Beyond  Johns Hopkins Medicine

Research Advances in Otology at Johns Hopkins and Beyond - Johns Hopkins Medicine

Click here to get full coverage on Pain Threshold Predictive of Fatigue Severity in SCD, Study Finds - AJMC

Pain Threshold Predictive of Fatigue Severity in SCD, Study Finds  AJMC

Pain Threshold Predictive of Fatigue Severity in SCD, Study Finds - AJMC

Click here to get full coverage on SCD Trial Effectively Implements TCD Screening Protocol in Resource-Constrained Settings - Docwire News

SCD Trial Effectively Implements TCD Screening Protocol in Resource-Constrained Settings  Docwire News

SCD Trial Effectively Implements TCD Screening Protocol in Resource-Constrained Settings - Docwire News

Click here to get full coverage on BA splits with SCDS in basketball season opener - Grice Connect

BA splits with SCDS in basketball season opener  Grice Connect

BA splits with SCDS in basketball season opener - Grice Connect

Click here to get full coverage on Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease | Molecular Psychiatry - Nature

Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease | Molecular Psychiatry  Nature

Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease | Molecular Psychiatry - Nature

Click here to get full coverage on Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models | Communications Biology - Nature

Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models | Communications Biology  Nature

Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models | Communications Biology - Nature

Click here to get full coverage on Ultraprocessed Foods Tied to Higher Cancer Risk: Mingyang Song, MBBS, ScD - AJMC

Ultraprocessed Foods Tied to Higher Cancer Risk: Mingyang Song, MBBS, ScD  AJMC

Ultraprocessed Foods Tied to Higher Cancer Risk: Mingyang Song, MBBS, ScD - AJMC

Click here to get full coverage on SCDS: a rare balance disorder that proved to be all in the head - The Guardian

SCDS: a rare balance disorder that proved to be all in the head  The Guardian

SCDS: a rare balance disorder that proved to be all in the head - The Guardian

Click here to get full coverage on Dennis Delisle, ScD, FACHE - The Ohio State University Wexner Medical Center

Dennis Delisle, ScD, FACHE  The Ohio State University Wexner Medical Center

Dennis Delisle, ScD, FACHE - The Ohio State University Wexner Medical Center

Click here to get full coverage on Savannah Country Day Faculty Explorations series begins with the secret to smarter kids - Savannah Morning News

Savannah Country Day Faculty Explorations series begins with the secret to smarter kids  Savannah Morning News

Savannah Country Day Faculty Explorations series begins with the secret to smarter kids - Savannah Morning News

Click here to get full coverage on A Simple Specific Functional Test for SCD: VEMPs to High Frequency (4,000Hz) Stimuli—Their Origin and Explanation - Frontiers

A Simple Specific Functional Test for SCD: VEMPs to High Frequency (4,000Hz) Stimuli—Their Origin and Explanation  Frontiers

A Simple Specific Functional Test for SCD: VEMPs to High Frequency (4,000Hz) Stimuli—Their Origin and Explanation - Frontiers

Click here to get full coverage on Study: Patients With SCD Report Discrimination Based on Race, Pain, and Other Factors - AJMC

Study: Patients With SCD Report Discrimination Based on Race, Pain, and Other Factors  AJMC

Study: Patients With SCD Report Discrimination Based on Race, Pain, and Other Factors - AJMC

Click here to get full coverage on Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance - Haematologica

Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance  Haematologica

Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance - Haematologica

Click here to get full coverage on The Benefits of More Sickle Cell Retinopathy Screening for Patients With SCD - AJMC

The Benefits of More Sickle Cell Retinopathy Screening for Patients With SCD  AJMC

The Benefits of More Sickle Cell Retinopathy Screening for Patients With SCD - AJMC

Click here to get full coverage on Etavopivat Well-Tolerated With Some Disease-Modifying Activity in SCD - HCPLive

Etavopivat Well-Tolerated With Some Disease-Modifying Activity in SCD  HCPLive

Etavopivat Well-Tolerated With Some Disease-Modifying Activity in SCD - HCPLive

Click here to get full coverage on Practicality of multilayer round window reinforcement in the surgical management of superior semicircular canal dehiscence syndrome: a case report of long-term follow-up - Frontiers

Practicality of multilayer round window reinforcement in the surgical management of superior semicircular canal dehiscence syndrome: a case report of long-term follow-up  Frontiers

Practicality of multilayer round window reinforcement in the surgical management of superior semicircular canal dehiscence syndrome: a case report of long-term follow-up - Frontiers

Click here to get full coverage on Conquering SCD by Confronting Treatment Barriers, Investigating PROs - AJMC

Conquering SCD by Confronting Treatment Barriers, Investigating PROs  AJMC

Conquering SCD by Confronting Treatment Barriers, Investigating PROs - AJMC

Click here to get full coverage on Sickle Cell Patients Are Living a Decade Longer in 2022 Than in 2008 - Epic Research

Sickle Cell Patients Are Living a Decade Longer in 2022 Than in 2008  Epic Research

Sickle Cell Patients Are Living a Decade Longer in 2022 Than in 2008 - Epic Research

Click here to get full coverage on 1st SCD patient outside US receives gene-editing therapy Casgevy - Sickle Cell Disease News

1st SCD patient outside US receives gene-editing therapy Casgevy  Sickle Cell Disease News

1st SCD patient outside US receives gene-editing therapy Casgevy - Sickle Cell Disease News

Click here to get full coverage on VOC Frequency Negatively Associated With HRQOL in Children, Caregivers Living With SCD - AJMC

VOC Frequency Negatively Associated With HRQOL in Children, Caregivers Living With SCD  AJMC

VOC Frequency Negatively Associated With HRQOL in Children, Caregivers Living With SCD - AJMC

Click here to get full coverage on Decreased Levels of Zinc Associated With Worse SCD Severity in Children, Adolescents - AJMC

Decreased Levels of Zinc Associated With Worse SCD Severity in Children, Adolescents  AJMC

SCDS

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About SCDS

Latest News

POST-SCD Investigations Provide Insights Into Community Burden of SCD - American College of Cardiology

A Review of SCDS’s ‘Journey Through Ruth’ - The Commentator

Behavioral Patterns of SCDS and Institutional Flows - news.stocktradersdaily.com

Advanced Charts

Fund Information